Consolidated Statement of Operations - USD ($)	3 Months Ended		6 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021
Details
Revenues	$ 1,344,953	$ 1,461,844	$ 2,856,618	$ 3,159,765
Operating expenses
Cost of revenues	1,094,469	565,451	1,884,386	1,135,124
Research and development expenses	89,056	53,251	156,927	100,883
Selling, general, and administrative expenses	1,271,437	635,965	2,088,689	1,314,784
Operating Expenses	2,454,962	1,254,667	4,130,002	2,550,791
Income/(Loss) from operations	(1,110,009)	207,177	(1,273,384)	608,974
Interest expense - related party	264,754	257,713	531,154	524,113
Income/(Loss) before income taxes	(1,374,763)	(50,536)	(1,804,538)	84,861
Provision for income taxes	0	0	0	0
Net Income/(Loss)	$ (1,374,763)	$ (50,536)	$ (1,804,538)	$ 84,861
Net income/(loss) per common share - basic	$ (0.18)	$ (0.01)	$ (0.23)	$ 0.01
Net income/(loss) per common share - diluted	$ (0.18)	$ (0.01)	$ (0.23)	$ 0.01
Weighted average number of common shares outstanding - basic	7,712,091	7,712,091	7,712,091	7,712,091
Weighted average number of common shares outstanding - diluted	7,712,091	7,712,091	7,712,091	7,712,091